SEARCH

SEARCH BY CITATION

References

  • 1
    Sakaguchi, S., Yamaguchi, T., Nomura, T. and Ono, M., Regulatory T cells and immune tolerance. Cell 2008. 133: 775787.
  • 2
    Shevach, E. M., Mechanisms of foxp3+ T regulatory cell-mediated suppression. Immunity 2009. 30: 636645.
  • 3
    Sakaguchi, S., Miyara, M., Costantino, C. M. and Hafler, D. A., FOXP3+ regulatory T cells in the human immune system. Nat. Rev. Immunol. 2010. 10: 490500.
  • 4
    Allan, S. E., Broady, R., Gregori, S., Himmel, M. E., Locke, N., Roncarolo, M. G., Bacchetta, R. et al., CD4+ T-regulatory cells: toward therapy for human diseases. Immunol. Rev. 2008. 223: 391421.
  • 5
    Wang, J., Ioan-Facsinay, A., van der Voort, E. I., Huizinga, T. W. and Toes, R. E., Transient expression of FOXP3 in human activated nonregulatory CD4+ T cells. Eur. J. Immunol. 2007. 37: 129138.
  • 6
    Tran, D. Q., Ramsey, H. and Shevach, E. M., Induction of FOXP3 expression in naive human CD4+FOXP3 T cells by T-cell receptor stimulation is transforming growth factor-beta dependent but does not confer a regulatory phenotype. Blood 2007. 110: 29832990.
  • 7
    Allan, S. E., Crome, S. Q., Crellin, N. K., Passerini, L., Steiner, T. S., Bacchetta, R., Roncarolo, M. G. et al., Activation-induced FOXP3 in human T effector cells does not suppress proliferation or cytokine production. Int. Immunol. 2007. 19: 345354.
  • 8
    Gavin, M. A., Torgerson, T. R., Houston, E., DeRoos, P., Ho, W. Y., Stray-Pedersen, A., Ocheltree, E. L. et al., Single-cell analysis of normal and FOXP3-mutant human T cells: FOXP3 expression without regulatory T cell development. Proc. Natl. Acad. Sci. USA 2006. 103: 66596664.
  • 9
    Morgan, M. E., van Bilsen, J. H., Bakker, A. M., Heemskerk, B., Schilham, M. W., Hartgers, F. C., Elferink, B. G. et al., Expression of FOXP3 mRNA is not confined to CD4+CD25+ T regulatory cells in humans. Hum. Immunol. 2005. 66: 1320.
  • 10
    Sakaguchi, S., Sakaguchi, N., Asano, M., Itoh, M. and Toda, M., Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor alpha-chains (CD25). Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases. J. Immunol. 1995. 155: 11511164.
  • 11
    Thornton, A. M. and Shevach, E. M., CD4+CD25+ immunoregulatory T cells suppress polyclonal T cell activation in vitro by inhibiting interleukin 2 production. J. Exp. Med. 1998. 188: 287296.
  • 12
    Takahashi, T., Kuniyasu, Y., Toda, M., Sakaguchi, N., Itoh, M., Iwata, M., Shimizu, J. et al., Immunologic self-tolerance maintained by CD25+CD4+ naturally anergic and suppressive T cells: induction of autoimmune disease by breaking their anergic/suppressive state. Int. Immunol. 1998. 10: 19691980.
  • 13
    Crellin, N. K., Garcia, R. V., Hadisfar, O., Allan, S. E., Steiner, T. S. and Levings, M. K., Human CD4+ T cells express TLR5 and its ligand flagellin enhances the suppressive capacity and expression of FOXP3 in CD4+CD25+ T regulatory cells. J. Immunol. 2005. 175: 80518059.
  • 14
    Schneider, A. and Buckner, J. H., Assessment of suppressive capacity by human regulatory T cells using a reproducible, bi-directional CFSE-based in vitro assay. Methods Mol. Biol. 2011. 707: 233241.
  • 15
    Baecher-Allan, C., Wolf, E. and Hafler, D. A., Functional analysis of highly defined, FACS-isolated populations of human regulatory CD4+ CD25+ T cells. Clin. Immunol. 2005. 115: 1018.
  • 16
    Levings, M. K., Sangregorio, R. and Roncarolo, M. G., Human cd25(+)cd4(+) t regulatory cells suppress naive and memory T cell proliferation and can be expanded in vitro without loss of function. J. Exp. Med. 2001. 193: 12951302.
  • 17
    Walker, L. S., Chodos, A., Eggena, M., Dooms, H. and Abbas, A. K., Antigen-dependent proliferation of CD4+ CD25+ regulatory T cells in vivo. J. Exp. Med. 2003. 198: 249258.
  • 18
    Allan, S. E., Alstad, A. N., Merindol, N., Crellin, N. K., Amendola, M., Bacchetta, R., Naldini, L. et al., Generation of potent and stable human CD4+ T regulatory cells by activation-independent expression of FOXP3. Mol. Ther. 2008. 16: 194202.
  • 19
    Oberle, N., Eberhardt, N., Falk, C. S., Krammer, P. H. and Suri-Payer, E., Rapid suppression of cytokine transcription in human CD4+CD25 T cells by CD4+Foxp3+ regulatory T cells: independence of IL-2 consumption, TGF-beta, and various inhibitors of TCR signaling. J. Immunol. 2007. 179: 35783587.
  • 20
    Ruitenberg, J. J., Boyce, C., Hingorani, R., Putnam, A. and Ghanekar, S. A., Rapid assessment of in vitro expanded human regulatory T cell function. J. Immunol. Methods 2011. 372: 95106.
  • 21
    Venken, K., Thewissen, M., Hellings, N., Somers, V., Hensen, K., Rummens, J. L. and Stinissen, P., A CFSE based assay for measuring CD4+CD25+ regulatory T cell mediated suppression of auto-antigen specific and polyclonal T cell responses. J. Immunol. Methods 2007. 322: 111.
  • 22
    Parish, C. R., Fluorescent dyes for lymphocyte migration and proliferation studies. Immunol. Cell Biol. 1999. 77: 499508.
  • 23
    Crome, S. Q., Clive, B., Wang, A. Y., Kang, C. Y., Chow, V., Yu, J., Lai, A. et al., Inflammatory effects of ex vivo human Th17 cells are suppressed by regulatory T cells. J. Immunol. 2010. 185: 31993208.
  • 24
    Sakaguchi, S., Wing, K., Onishi, Y., Prieto-Martin, P. and Yamaguchi, T., Regulatory T cells: how do they suppress immune responses? Int. Immunol. 2009. 21: 11051111.
  • 25
    Taams, L. S., Smith, J., Rustin, M. H., Salmon, M., Poulter, L. W. and Akbar, A. N., Human anergic/suppressive CD4(+)CD25(+) T cells: a highly differentiated and apoptosis-prone population. Eur. J. Immunol. 2001. 31: 11221131.
  • 26
    Baecher-Allan, C., Brown, J. A., Freeman, G. J. and Hafler, D. A., CD4+CD25high regulatory cells in human peripheral blood. J. Immunol. 2001. 167: 12451253.
  • 27
    Janson, P. C., Winerdal, M. E., Marits, P., Thorn, M., Ohlsson, R. and Winqvist, O., FOXP3 promoter demethylation reveals the committed Treg population in humans. PLoS One 2008. 3: e1612.
  • 28
    Floess, S., Freyer, J., Siewert, C., Baron, U., Olek, S., Polansky, J., Schlawe, K. et al., Epigenetic control of the foxp3 locus in regulatory T cells. PLoS Biol. 2007. 5: e38.
  • 29
    Miyara, M., Yoshioka, Y., Kitoh, A., Shima, T., Wing, K., Niwa, A., Parizot, C. et al., Functional delineation and differentiation dynamics of human CD4+ T cells expressing the FoxP3 transcription factor. Immunity 2009. 30: 899911.
  • 30
    Hoffmann, P., Eder, R., Boeld, T. J., Doser, K., Piseshka, B., Andreesen, R. and Edinger, M., Only the CD45RA+ subpopulation of CD4+CD25high T cells gives rise to homogeneous regulatory T-cell lines upon in vitro expansion. Blood 2006. 108: 42604267.
  • 31
    Dwyer, K. M., Hanidziar, D., Putheti, P., Hill, P. A., Pommey, S., McRae, J. L., Winterhalter, A. et al., Expression of CD39 by human peripheral blood CD4+ CD25+ T cells denotes a regulatory memory phenotype. Am. J. Transplant. 2010. 10: 24102420.
  • 32
    Liu, W., Putnam, A. L., Xu-Yu, Z., Szot, G. L., Lee, M. R., Zhu, S., Gottlieb, P. A. et al., CD127 expression inversely correlates with FoxP3 and suppressive function of human CD4+ T reg cells. J. Exp. Med. 2006. 203: 17011711.
  • 33
    Seddiki, N., Santner-Nanan, B., Martinson, J., Zaunders, J., Sasson, S., Landay, A., Solomon, M. et al., Expression of interleukin (IL)-2 and IL-7 receptors discriminates between human regulatory and activated T cells. J. Exp. Med. 2006. 203: 16931700.
  • 34
    Baecher-Allan, C., Wolf, E. and Hafler, D. A., MHC class II expression identifies functionally distinct human regulatory T cells. J. Immunol. 2006. 176: 46224631.
  • 35
    Marwaha, A. K., Crome, S. Q., Panagiotopoulos, C., Berg, K. B., Qin, H., Ouyang, Q., Xu, L. et al., Cutting edge: increased IL-17-secreting T cells in children with new-onset type 1 diabetes. J. Immunol. 2010. 185: 38143818.
  • 36
    Kimura, A. and Kishimoto, T., IL-6: regulator of Treg/Th17 balance. Eur. J. Immunol. 2010. 40: 18301835.
  • 37
    Broady, R., Yu, J. and Levings, M. K., ATG-induced expression of FOXP3 in human CD4(+) T cells in vitro is associated with T-cell activation and not the induction of FOXP3(+) T regulatory cells. Blood 2009. 114: 50035006.
  • 38
    Levings, M. K., Gregori, S., Tresoldi, E., Cazzaniga, S., Bonini, C. and Roncarolo, M. G., Differentiation of Tr1 cells by immature dendritic cells requires IL-10 but not CD25+CD4+ Tr cells. Blood 2005. 105: 11621169.
  • 39
    Pillai, V., Ortega, S. B., Wang, C. K. and Karandikar, N. J., Transient regulatory T-cells: a state attained by all activated human T-cells. Clin. Immunol. 2007. 123: 1829.
  • 40
    Walker, M. R., Kasprowicz, D. J., Gersuk, V. H., Benard, A., Van Landeghen, M., Buckner, J. H. and Ziegler, S. F., Induction of FoxP3 and acquisition of T regulatory activity by stimulated human CD4+CD25- T cells. J. Clin. Invest. 2003. 112: 14371443.
  • 41
    Golovina, T. N., Mikheeva, T., Suhoski, M. M., Aqui, N. A., Tai, V. C., Shan, X., Liu, R. et al., CD28 costimulation is essential for human T regulatory expansion and function. J. Immunol. 2008. 181: 28552868.
  • 42
    Dige, A., Hvas, C. L., Kelsen, J., Deleuran, B., Dahlerup, J. F. and Agnholt, J., Ethylene-Diamine-Tetra-Acetate (EDTA) mimics the effect of regulatory T cells in suppression assays: a potential pitfall when using AutoMACS-separated cells. J. Immunol. Methods 2009. 353: 141144.
  • 43
    Baecher-Allan, C., Viglietta, V. and Hafler, D. A., Inhibition of human CD4(+)CD25(+high) regulatory T cell function. J. Immunol. 2002. 169: 62106217.
  • 44
    Baecher-Allan, C. M., Costantino, C. M., Cvetanovich, G. L., Ashley, C. W., Beriou, G., Dominguez-Villar, M. and Hafler, D. A., CD2 costimulation reveals defective activity by human CD4+CD25hi regulatory cells in patients with multiple sclerosis. J. Immunol. 2011. 186: 33173326.
  • 45
    Shalev, I., Schmelzle, M., Robson, S. C. and Levy, G., Making sense of regulatory T cell suppressive function. Semin. Immunol. 2011. 23: 282292.
  • 46
    Onishi, Y., Fehervari, Z., Yamaguchi, T. and Sakaguchi, S., Foxp3+ natural regulatory T cells preferentially form aggregates on dendritic cells in vitro and actively inhibit their maturation. Proc. Natl. Acad. Sci. USA 2008. 105: 1011310118.
  • 47
    Wang, A. Y., Crome, S. Q., Jenkins, K. M., Medin, J. A., Bramson, J. L. and Levings, M. K., Adenoviral-transduced dendritic cells are susceptible to suppression by T regulatory cells and promote interleukin 17 production. Cancer Immunol. Immunother. 2011. 60: 381388.
  • 48
    Putnam, A. L., Brusko, T. M., Lee, M. R., Liu, W., Szot, G. L., Ghosh, T., Atkinson, M. A. et al., Expansion of human regulatory T-cells from patients with type 1 diabetes. Diabetes 2009. 58: 652662.
  • 49
    Levings, M. K., Sangregorio, R., Sartirana, C., Moschin, A. L., Battaglia, M., Orban, P. C. and Roncarolo, M. G., Human CD25+CD4+ T suppressor cell clones produce transforming growth factor beta, but not interleukin 10, and are distinct from type 1 T regulatory cells. J. Exp. Med. 2002. 196: 13351346.
  • 50
    Jonuleit, H., Schmitt, E., Stassen, M., Tuettenberg, A., Knop, J. and Enk, A. H., Identification and functional characterization of human CD4(+)CD25(+) T cells with regulatory properties isolated from peripheral blood. J. Exp. Med. 2001. 193: 12851294.
  • 51
    Chaturvedi, V., Collison, L. W., Guy, C. S., Workman, C. J. and Vignali, D. A., Cutting edge: human regulatory T cells require IL-35 to mediate suppression and infectious tolerance. J. Immunol. 2011. 186: 66616666.
  • 52
    Kubach, J., Lutter, P., Bopp, T., Stoll, S., Becker, C., Huter, E., Richter, C. et al., Human CD4+CD25+ regulatory T cells: proteome analysis identifies galectin-10 as a novel marker essential for their anergy and suppressive function. Blood 2007. 110: 15501558.
  • 53
    Andersson, J., Tran, D. Q., Pesu, M., Davidson, T. S., Ramsey, H., O'Shea, J. J. and Shevach, E. M., CD4+ FoxP3+ regulatory T cells confer infectious tolerance in a TGF-beta-dependent manner. J. Exp. Med. 2008. 205: 19751981.
  • 54
    Jonuleit, H., Schmitt, E., Kakirman, H., Stassen, M., Knop, J. and Enk, A. H., Infectious tolerance: human CD25(+) regulatory T cells convey suppressor activity to conventional CD4(+) T helper cells. J. Exp. Med. 2002. 196: 255260.
  • 55
    Francis, R. S., Feng, G., Tha-In, T., Lyons, I. S., Wood, K. J. and Bushell, A., Induction of transplantation tolerance converts potential effector T cells into graft-protective regulatory T cells. Eur. J. Immunol. 2011. 41: 726738.
  • 56
    McClymont, S. A., Putnam, A. L., Lee, M. R., Esensten, J. H., Liu, W., Hulme, M. A., Hoffmuller, U. et al., Plasticity of human regulatory T cells in healthy subjects and patients with type 1 diabetes. J. Immunol. 2011. 186: 39183926.
  • 57
    Beriou, G., Costantino, C. M., Ashley, C. W., Yang, L., Kuchroo, V. K., Baecher-Allan, C. and Hafler, D. A., IL-17-producing human peripheral regulatory T cells retain suppressive function. Blood 2009. 113: 42404249.
  • 58
    Crome, S. Q., Wang, A. Y. and Levings, M. K., Translational mini-review series on Th17 cells: function and regulation of human T helper 17 cells in health and disease. Clin. Exp. Immunol. 2010. 159: 109119.
  • 59
    Sakaguchi, S., Immunology: Conditional stability of T cells. Nature 2010. 468: 4142.
  • 60
    Brunstein, C. G., Miller, J. S., Cao, Q., McKenna, D. H., Hippen, K. L., Curtsinger, J., Defor, T. et al., Infusion of ex vivo expanded T regulatory cells in adults transplanted with umbilical cord blood: safety profile and detection kinetics. Blood 2010. 117: 10611070.
  • 61
    Di Ianni, M., Falzetti, F., Carotti, A., Terenzi, A., Castellino, F., Bonifacio, E., Del Papa, B. et al., Tregs prevent GvHD and promote immune reconstitution in HLA-haploidentical transplantation. Blood 2011. 117: 39213928.
  • 62
    Palomares, O., Yaman, G., Azkur, A. K., Akkoc, T., Akdis, M. and Akdis, C. A., Role of Treg in immune regulation of allergic diseases. Eur. J. Immunol. 2010. 40: 12321240.